The effect of vitronectin and other extracellular matrix molecules on endothelial expansion and plasminogen activation

Cells and Materials

Volumn 6, Issue 1-3, 1996, Pages 193-207

  Underwood, P Anne ^a   Bean, Penny A ^a  

^a CSIRO   (Australia)

Author keywords

Adhesion; Endothelium; Expansion assay; Extracellular matrix; Migration; Plasminogen activator; Vitronectin

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRONECTIN; LAMININ; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; VITRONECTIN;

ARTERY INTIMA PROLIFERATION; ARTICLE; CELL ADHESION; CELL MIGRATION; ENDOTHELIUM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; TISSUE CULTURE; UMBILICAL ARTERY;

EID: 0030324792     PISSN: 10516794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Bale MD, Wolfahrt LA, Mosher DF, Tomasini B, Sutton RC. (1989). Identification of vitronectin as a major plasma protein adsorbed on polymer surfaces of different copolymer composition. Blood 74: 2698-2706.
2. Casscells W. (1992). Migration of smooth muscle and endothelial cells - critical events in restenosis. Circulation 86: 723-729.
3. Ciambrone GJ, McKeown-Longo PJ. (1990). Plasminogen activator inhibitor type I stabilises vitronectin-dependent adhesions in HT-1080 cells. J Cell Biol 111: 2183-2195.
4. Ciambrone GJ, McKeown-Longo PJ. (1992). Vitronectin regulates the synthesis and localization of urokinase-type plasminogen activator in HT-1080 cells. J Biol Chem 267: 13617-13622.
5. Clowes AW, Reidy MA, Clowes MM. (1983). Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49: 327-333.
6. Clyman RI, Tannenbaum J, Chen YQ, Cooper D, Yurchenco PD, Kramer RH, Waleh NS. (1994). Ductus arteriosus smooth muscle cell migration on collagen dependence on laminin and its receptors. J Cell Sci 107: 1007-1018.
7. Colquhoun D. (1971). Lectures on Biostatistics. Clarendon Press. Oxford, pp 1-425.
8. DeLisser HM, Newman PJ, Albeda SM. (1994). Molecular and functional aspects of PECAM-1/CD31. Immunol Today 15: 490-495.
9. Doornekamp FNG, Borst C, Post MJ. (1996). Endothelial cell recoverage and intimal hyperplasia after endothelium removal with or without smooth muscle cell necrosis in the rabbit carotid artery. J Vasc Res 33: 146- 155.
10. Fischer EG, Stingl A, Kirkpatrick CJ. (1990). Migration assay for endothelial cells in multiwells. Application to studies on the effect of opiods. J Immunol Methods 128: 235-239.
11. Folkman J, Moscona A. (1978). Role of cell shape in growth control. Nature 273 : 345-349.
12. Goldberg S, Savage MP, Fischman DL. (1995). Coronary artery stents. Lancet 345 : 1523-1524.
13. Gospodarowicz D, Lui GM. (1981). Effect of substrata and fibroblast growth factor on the proliferation in vitro of bovine aortic endothelial cells. J Cell Physiol 109: 69-81.
14. Grulich-Henn J, Mullerberghaus G, Preissner KT. (1992). The influence of growth substratum and cell activation on the deposition of plasminogen activator inhibitor-1 in the extracellular matrix of human endothelial cells. Fibrinolysis 6: 131-137.
15. Guettier C, Hinglais N, Bruneval P, Kazatchkine M, Bariety J, Camilleri J. (1989). Immunohistochemical localisation of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries. Virchows Arch A Pathol Anat 414: 309-313.
16. Hayward IP, Bridle KR, Campbell GR, Underwood PA, Campbell JH. (1995). Effect of extracellular matrix proteins on vascular smooth muscle cell phenotype. Cell Biol Intl 19: 727-734.
17. Herman I. (1987). Extracellular matrix-cytoskeletal interactions in vascular cells. Tissue & Cell 19: 1-19.
18. Horbett TA. (1994). The role of adsorbed proteins in animal cell adhesion. Colloids & Surfaces B: Biointerfaces 2: 225-240.
19. Ingber DE. (1990). Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc Natl Acad Sci USA 87: 3579-3583.
20. Ingber DE. (1991). Control of capillary growth and differentiation by extracellular matrix - Use of a tensegrity (tensional integrity) mechanism for signal processing. Chest 99: S34-S40.
21. Ingber DE, Folkman J. (1989). Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: Role of extracellular matrix. J Cell Biol 109: 317-330.
22. Ingber DE, Madri JA, Folkman J. (1987). Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion. In Vitro Cell Devel Biol 23: 387- 394.
23. Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, Ruco LP, Dejana E. (1992). A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 118: 1511-1522.
24. Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EKO. (1993). Localisation and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arteriosclerosis & Thrombosis 13: 1090-1100.
25. Maciag T, Cerundolo J, Ilsley S, Kelly PR, Forand R. (1979). An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterisation. Proc Natl Acad Sci USA 76: 5674-5678.
26. Madri JA, Marx M. (1992). Matrix composition, organization and soluble factors - modulators of microvascular cell differentiation in vitro. Kidney Int 41: 560-565.
27. Madri JA, Stenn KS. (1982). Aortic endothelial cell migration. I. Matrix requirements and composition. Am J Pathol 106: 180-186.
28. Madri JA, Pratt BM, Yannariello-Brown J. (1988). Matrix-driven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am J Pathol 132: 18-27.
29. Madri JA, Reidy MA, Kocher O, Bell L. (1989). Endothelial cell behaviour after denudation injury is modulated by transforming growth factor-beta1 and fibronectin. Lab Invest 60: 755-765.
30. Madri JA, Merwin JR, Bell L, Basson CT, Kocher O, Perlmutter R, Prinz C. (1992). Interactions of matrix components and soluble factors in vascular responses to injury - modulation of cell phenotype. In: Endothelial Cell Dysfunctions. Simonescu N, Simonescu M (eds.). Plenum Press, New York, pp. 11-30.
31. Morris CA, Underwood PA, Bean PA, Sheehan M, Charlesworth JA. (1994). Relative topography of biologically active domains of human vitronectin. Evidence from monoclonal antibody epitope and denaturation studies. J Biol Chem 269: 23845-23852.
32. Moser TL, Enghild JJ, Pizzo SV, Stack MS. (1995). Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. Biochem J 307: 867-873.
33. Nicolescu F, Rus HG, Vlaicu R. (1987) Immunohistochemical localisation of C5b-9, S-protein, C3d and lipoprotein Bin human arterial tissues with atherosclerosis. Atherosclerosis 65: 1-11.
34. Nicolescu F, Rus HG, Porutiu D, Ghiurca V. (1989). Immunoelectron-microscopic localisation of S- protein/vitronectin in human atherosclerotic wall. Atherosclerosis 78: 197-203.
35. Oliver MH, Harrison NK, Bishop JE, Cole PJ, Laurent GJ. (1989). A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci. 92: 513- 518.
36. Pepper MS, Sappino AP, Montesano R, Orci L, Vassalli JD (1992), Plasminogen activator inhibitor-1 is induced in migrating endothelial cells. J Cell Physiol 153: 129-139.
37. Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L, Vassalli JD. (1993). Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 122: 673-684.
38. Preissner KT, Potzsch B. (1995). Vessel wall- dependent metabolic pathways of the adhesive proteins, von-Willebrand-factor and vitronectin. Histol Histopathol 10: 239-251.
39. Preissner KT, Kost C, Rosenblatt S, Deboer H, Hammes HP, Pannekoek H. (1993). The role of fibrinolysis in the cross-talks among vessel wall components - the Vitronectin-PAI-1 axis. Fibrinolysis 7: 18-19.
40. Reidy MA, Standaert D, Schwartz SM (1982). Inhibition of endothelial cell regrowth. Cessation of aortic endothelial cell replication after balloon catheter denudation. Arteriosclerosis 2: 216-220.
41. Ribeiro SMF, Schultzcherry S, Murphyullrich JE. (1995). Heparin-binding vitronectin up-regulates latent TGF-beta production by bovine aortic endothelial cells. J Cell Sci 108: 1553-1561.
42. Rogers C, Edelman ER. (1995). Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 91: 2995-3001.
43. Ruoslhati E, Hayman EG, Pierschbacher M, Engvall E. (1982). Fibronectin: purification, immunochemical properties and biological activities. Methods in Enzymol 82: 803-831.
44. Schwartz SM, Gajdusek CM, Reidy MA, Selden SC, Haudenschild CC. (1980). Maintenance of integrity in aortic endothelium. Fed Proc 39: 2618-2625.
45. Steele JG, Dalton BA, Johnson G, Underwood PA. (1993). Polystyrene chemistry affects vitronectin activity: an explanation for cell attachment to tissue culture polystyrene but not to unmodified polystyrene. J Biomed Mat Res 27: 927-940.
46. Tomasini BR, Mosher DF. (1991). Vitronectin. Prog in Haemost Thrombosis 10: 269-305.
47. Underwood PA, Bennett FA. (1989). A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin. J Cell Sci 93: 641-649.
48. Underwood PA, Bennett FA. (1993). The effect of extracellular matrix molecules on the in vitro behaviour of bovine endothelial cells. Exp Cell Res 205: 311-319.
49. Underwood PA, Steele JG. (1991). Practical limitations of estimation of protein adsorption to polymer surfaces. J Immunol Meth 142: 83-94.
50. Underwood PA, Dalton BA, Steele JG, Bennett FA, Strike P. (1992). Anti-fibronectin antibodies that modify heparin binding and cell adhesion: evidence for a new cell binding site in the heparin binding region. J Cell Sci 102: 833-845.
51. Underwood PA, Steele JG, Dalton BA. (1993). Effects of polystyrene surface chemistry on the biological activity of solid phase fibronectin and vitronectin, analysed with monoclonal antibodies. J Cell Sci 104: 793-803.
52. van Hinsbergh VWM. (1992). Impact of endothelial activation on fibrinolysis and local proteolysis in tissue repair. In: Plasminogen Activation in Fibrinolysis, in Tissue Remodeling, and in Development. Brakman P, Kluft C (eds.). Ann New York Acad Sci 667: 151-162.
53. Waltz DA, Chapman HA. (1994). Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem 269: 14746-14750.
54. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. (1994). Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269: 32380-32388.
55. Weis JR, Sun B, Rodgers GM. (1991). Improved method of human umbilical arterial endothelial cell culture. Thrombosis Res 61: 171-173.
56. Yamada KM. (1991). Fibronectin and other cell interactive glycoproteins. In: Cell Biology of Extracellular Matrix, Second Edition. Hay ED (ed.). Plenum Press, New York. pp. 111-146.